The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial
Official Title: Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial
Study ID: NCT00200096
Brief Summary: In a previous study, we found that acupuncture may decrease fatigue. The aim of this study is to determine whether acupuncture is helpful in reducing fatigue in cancer patients treated with chemotherapy. We will also study how fatigue, quality of life, mood, level of physical activity. This study will involve about 88 patients.
Detailed Description: Primary objective: To determine whether acupuncture reduces chronic fatigue after chemotherapy more effectively than placebo Secondary objectives: 1. To examine the long-term effects of acupuncture treatment on fatigue 2. To examine predictors of response to acupuncture treatment in terms of baseline symptoms, hemoglobin, age, sex, time since chemotherapy and concurrent treatment 3. To examine the effect of acupuncture on levels of physical activity and quality of life.
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: No
Memorial Sloan-Kettering Cancer Center, Basking Ridge, New Jersey, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Name: Gary Deng, MD, PhD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR